613 filings
Page 3 of 31
25-NSE
z5rd y3b1
3 Jun 24
Exchange delisting
3:40pm
8-K
tc1347j5lm
21 May 24
Entry into a Material Definitive Agreement
8:30am
8-K
qow 67fz8
15 May 24
Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
4:15pm
8-K
4gba87
9 Apr 24
Results of Operations and Financial Condition
8:30am
8-K
mlaq53jfhnoq4
28 Mar 24
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
9:06am
8-K
0ztk9f6bp6rxj
25 Mar 24
Agile Therapeutics Announces Delisting from Nasdaq
4:30pm
8-K
arg1zw1556t
14 Mar 24
Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
4:45pm
424B5
7yhvq 8h7m7q
23 Feb 24
Prospectus supplement for primary offering
4:57pm
424B5
77pcqeauhcqvtfclr3
23 Feb 24
Prospectus supplement for primary offering
4:55pm
8-K
gw14s6alig 9u
23 Feb 24
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
4:30pm
8-K
1o0olc
15 Feb 24
Net Revenue for Full Year 2023 Expected to be in the Range of $20 to $21 Million, an Increase of 84% to 93% Compared to Full Year 2022
4:45pm
SC 13G/A
dvul6pi4k36wb w8h
13 Feb 24
AGILE THERAPEUTICS / Lind Global Fund II ownership change
8:02pm
SC 13G/A
0qh6zvr3w9g8urn5f3
6 Feb 24
AGILE THERAPEUTICS / INTRACOASTAL CAPITAL ownership change
10:14am